Blue Square Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432K Hold
360
0.17% 46
2026
Q1
$331K Hold
360
0.16% 51
2025
Q4
$387K Hold
360
0.17% 51
2025
Q3
$275K Hold
360
0.12% 62
2025
Q2
$281K Hold
360
0.13% 60
2025
Q1
$297K Hold
360
0.16% 51
2024
Q4
$278K Hold
360
0.14% 62
2024
Q3
$319K Hold
360
0.17% 59
2024
Q2
$326K Hold
360
0.19% 59
2024
Q1
$280K Hold
360
0.19% 63
2023
Q4
$210K Buy
+360
New +$210K 0.14% 74
2022
Q4
Sell
-735
Closed -$238K 29
2022
Q3
$238K Hold
735
0.16% 23
2022
Q2
$238K Hold
735
0.51% 43
2022
Q1
$210K Hold
735
0.18% 65
2021
Q4
$203K Buy
+735
New +$186K 0.13% 81
2020
Q3
Sell
-735
Closed -$121K 135
2020
Q2
$121K Buy
+735
New +$113K 0.08% 88

Other funds holding LLY

Blue Square Asset Management's LLY Position: Q2 2026 in Review

Blue Square Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 360 shares worth $432K. The position accounts for 0.17% of the portfolio, ranked #46.

Blue Square Asset Management first reported a position in LLY in Q2 2020 and has held it in 16 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blue Square Asset Management held 360 shares of Eli Lilly worth $432K as of Q2 2026.
  • Blue Square Asset Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.17% of Blue Square Asset Management's portfolio in Q2 2026, its #46 holding.
  • Blue Square Asset Management first reported a position in Eli Lilly in Q2 2020 and has held it in 16 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blue Square Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.